Mesenchymal stromal cell therapy for liver diseases

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

The impact of hepatitis E in the liver transplant setting

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 50, Issue 4, Pages (April 2009)

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Tiny RNA with great effects: miR-155 in alcoholic liver disease

Hepatic CD141+IFNλ+ DC subset: One against all?

Pathological roles of purinergic signaling in the liver

Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR Nicolas Marsollier, Pascal Ferré,

The impact of hepatitis E in the liver transplant setting

Reactive oxygen species in the normal and acutely injured liver

Obesity, inflammation, and liver cancer

Cédric Coulouarn, Bruno Clément Journal of Hepatology

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Immigration and viral hepatitis

Volume 66, Issue 1, Pages 1-4 (January 2017)

The evidence supports a viral aetiology for primary biliary cirrhosis

Ype P. de Jong, Charles M. Rice, Alexander Ploss Journal of Hepatology

Living donor liver transplantation: is the hype over?

Nicolas Moniaux, Jamila Faivre Journal of Hepatology

Reply to: “DCD consensus and futility in liver transplantation”

The place of downstaging for hepatocellular carcinoma

The progenitor cell dilemma: Cellular and functional heterogeneity in assistance or escalation of liver injury Veronika Lukacs-Kornek, Frank Lammert

Autoimmune hepatitis: A life-long disease

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Volume 59, Issue 3, Pages (September 2013)

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

HCMV jogs the ‘memory’ of NK cells in HBV

The changing role of beta-blocker therapy in patients with cirrhosis

S. Tamir Rashid, Graeme J.M. Alexander Journal of Hepatology

Volume 57, Issue 5, Pages (November 2012)

Volume 50, Issue 4, Pages (April 2009)

Cédric Coulouarn, Bruno Clément Journal of Hepatology

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Volume 56, Issue 6, Pages (June 2012)

Immigration and viral hepatitis

The potential of induced pluripotent stem cell derived hepatocytes

Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability Markus Cornberg,

Global burden of alcoholic liver diseases

The impact of intestinal microflora on serum bilirubin levels

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Volume 51, Issue 2, Pages (August 2009)

The use of hemospray in portal hypertensive bleeding; a case series

Volume 66, Issue 4, Pages (April 2017)

New trials and results in systemic treatment of HCC

Liver transplantation in children

Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi

Reply to: “Flow cytometry makes all the difference”

Pathogenesis of cholestatic hepatitis C

The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: Mystery solved? Mario Strazzabosco, Luca Fabris

Chimeric mouse model of hepatitis B virus infection

A 360-degree overview of paediatric NAFLD: Recent insights

The origin of biliary strictures after liver transplantation: Is it the amount of epithelial injury or insufficient regeneration that counts? Negin Karimian,

Niya Aleksieva, Stuart J. Forbes Journal of Hepatology

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Volume 64, Issue 6, Pages (June 2016)

Presentation transcript:

Mesenchymal stromal cell therapy for liver diseases Mohammed Alfaifi, Young Woo Eom, Philip N. Newsome, Soon Koo Baik Journal of Hepatology Volume 68, Issue 6, Pages 1272-1285 (June 2018) DOI: 10.1016/j.jhep.2018.01.030 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Modes of MSC-based therapy. MSC, mesenchymal stromal cell. Journal of Hepatology 2018 68, 1272-1285DOI: (10.1016/j.jhep.2018.01.030) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Potential mechanisms of the MSC interactions with immune cells. MSC, mesenchymal stromal cell; NK, natural killer. Journal of Hepatology 2018 68, 1272-1285DOI: (10.1016/j.jhep.2018.01.030) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Schematic diagram illustrating the future of using modified MSCs for tissue/organ regeneration. MSC, mesenchymal stromal cell. Journal of Hepatology 2018 68, 1272-1285DOI: (10.1016/j.jhep.2018.01.030) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions